Prospective Observational Study of SynCone® Concept

Sponsor
Marcio Zaffalon Casati (Other)
Overall Status
Recruiting
CT.gov ID
NCT03957265
Collaborator
Dentsply Sirona Implants (Industry)
15
1
1
12.5
1.2

Study Details

Study Description

Brief Summary

The aim of this prospective observational study will be to evaluate patient-related outcomes, clinical, microbiological and peri-implant immunoinflammatory mediators in completely edentulous patients rehabilitated with delayed loaded overdentures prostheses. The investigators hypothetize that this system could restore edentulous patients with healthier mucosal concerning clinical, microbiological and immunoinflammatory parameters, besides to promote improvement in patient satisfaction and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Tapered abutment connection
Phase 1

Detailed Description

This prospective observational study will include fifteen edentulous patients rehabilitated with conventional dentures. Patients will receive four to six maxillary implants loaded three months after surgery. Clinical, microbiological and immunoinflammatory parameters will be evaluated at baseline, three, and six months following overdenture prosthesis. Patient-centered/reported outcomes concerning general satisfaction with the prostheses as well as comfort, ability to speak, stability, esthetics, ease of cleaning and occlusion, will be evaluated at baseline (conventional denture evaluation) and after 6 months (overdenture evaluation).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective Observational Study of SynCone® Concept: Patient-related Outcomes, Clinical, Radiographic, Immunoinflammatory Mediators and Microbiological Analysis
Anticipated Study Start Date :
Mar 3, 2021
Anticipated Primary Completion Date :
Sep 17, 2021
Anticipated Study Completion Date :
Mar 17, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Syncone

Tapered abutment connection

Procedure: Tapered abutment connection
Rehabilitation of completely edentulous patients with overdentures prostheses.

Outcome Measures

Primary Outcome Measures

  1. Modified Gingival Index [6 months]

    Index of mucosal condition (Mombelli et al.1987): 0 - No bleeding when a periodontal probe is passed along the mucosal margin adjacent to the implant, 1 - Isolated bleeding spots visible, 2 - Blood forms a confluent red line on mucosal margin, 3 - Heavy or profuse bleeding

Secondary Outcome Measures

  1. Modified Plaque Index [6 months]

    Index of plaque accumulation (Mombelli et al.1987): 0 - No detection of plaque, Plaque only recognized by running a probe accross the smooth marginal surface of the implant, 2 - Plaque can be seen by the naked eye, 3 - Abundance of soft matter.

  2. Oral Healthy Impact Profile-14 (OHIP-14) [6 months]

    A questionnaire will be administered to evaluate patient centered outcomes with regards to prosthesis. It has 14 questions in which the patient answers between never (0), rarely (1), sometimes (2), repeatedly (3) and always (4).

  3. Microbiological assays [6 months]

    Peri-implant biofilm will be collected and Real Time PCR wil be performed to measure the absolute quantification of Aggregatibacter Actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis

  4. Concentration of osteoimmuneinflammatory mediators [6 months]

    Levels of osteoimmuneinflammatory mediators will be determined in the peri-implant fluid (IL-4, IL-17, IL-1β, IL-10, IL-6, IL-8, IL-23 and TNF-α)

  5. Crestal bone level [6 months]

    Periapical radiographs will be made to evaluate crestal bone level alteration.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • subject has total edentulous maxilla.

  • subject whose dental extractions occurred at least 6 months before treatment.

Exclusion Criteria:
  • pregnancy, lactation, smoking or ex-smokers, systemic conditions that could affect bone metabolism (e.g., immunologic disorders, diabetes), use of anti-inflammatory, biphosphonate, and immunosuppressive medications, subjects that required bone grafts before/during implant surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 School of dentistry - Paulista University UNIP São Paulo SP Brazil

Sponsors and Collaborators

  • Marcio Zaffalon Casati
  • Dentsply Sirona Implants

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marcio Zaffalon Casati, professor, Paulista University
ClinicalTrials.gov Identifier:
NCT03957265
Other Study ID Numbers:
  • 79380717.4.0000.5512
First Posted:
May 21, 2019
Last Update Posted:
Nov 10, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 10, 2020